Floatz logo

Therapeutic Asset Ratings

2,003 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Cyclophosphamide
Metastatic Adrenal Gland Pheochromocytoma
M.D. Anderson Cancer CenterP2CCC (53)
Cyclophosphamide
Metastatic Kidney Medullary Carcinoma
M.D. Anderson Cancer CenterP2CCC (53)
Cyclophosphamide
Metastatic Small Intestinal Adenocarcinoma
M.D. Anderson Cancer CenterP2CCC (53)
Cyclophosphamide
Optimization of Neoadjuvant Therapy
M.D. Anderson Cancer CenterP2CCC (53)
Cyclophosphamide
Peau d'Orange
M.D. Anderson Cancer CenterP2CCC (53)
Cyclophosphamide
Peritoneal High Grade Serous Adenocarcinoma
M.D. Anderson Cancer CenterP2CCC (53)
Cyclophosphamide
Phase 2
M.D. Anderson Cancer CenterP2CCC (53)
Cyclophosphamide
Poorly Differentiated Thyroid Gland Carcinoma
M.D. Anderson Cancer CenterP2CCC (53)
Cyclophosphamide
Recurrent High Grade Ovarian Serous Adenocarcinoma
M.D. Anderson Cancer CenterP2CCC (53)
Cyclophosphamide
t(11;14)(q13;q32)
M.D. Anderson Cancer CenterP2CCC (53)
Cyclophosphamide
Thyroid Gland Undifferentiated (Anaplastic) Carcinoma
M.D. Anderson Cancer CenterP2CCC (53)
Cyclophosphamide
Thyroid Gland Squamous Cell Carcinoma
M.D. Anderson Cancer CenterP2CCC (53)
Cyclophosphamide
Undifferentiated High Grade Pleomorphic Sarcoma Of Bone
M.D. Anderson Cancer CenterP2CCC (53)
Cyclophosphamide
Unresectable Adrenal Gland Pheochromocytoma
M.D. Anderson Cancer CenterP2CCC (53)
Cyclophosphamide
Vascular Neoplasm
M.D. Anderson Cancer CenterP2CCC (53)
Cytosin-Arabinosid
Acute Myeloid Leukemia, Inv(16)(P13.1;Q22)
M.D. Anderson Cancer CenterP2CCC (53)
Cytosin-Arabinosid
Acute Myeloid Leukemia, T(16;16)(P13.1;Q22)
M.D. Anderson Cancer CenterP2CCC (53)
Cytosin-Arabinosid
Blinatumomab
M.D. Anderson Cancer CenterP2CCC (53)
Cytosin-Arabinosid
Olverembatinib
M.D. Anderson Cancer CenterP2CCC (53)
Cytosin-Arabinosid
Phase II Clinical Trial
M.D. Anderson Cancer CenterP2CCC (53)
Danvatirsen
Colorectal Carcinoma
M.D. Anderson Cancer CenterP2CCC (53)
Danvatirsen
Mismatch Repair Deficiency
M.D. Anderson Cancer CenterP2CCC (53)
Danvatirsen
Exocrine Pancreatic Carcinoma
M.D. Anderson Cancer CenterP2CCC (53)
Danvatirsen
Colorectal Cancer
M.D. Anderson Cancer CenterP2CCC (53)
Danvatirsen
Lung Cancer
M.D. Anderson Cancer CenterP2CCC (53)
Showing 651 to 675 of 2,003 assets
PreviousPage 27 of 81Next